Join our webinar for insights into the benefits of undertaking
R&D clinical trials in Australia.
Explore pathways to set up a presence in Australia and to access Australia’s world class talent and facilities.
Learn more about the tax, R&D Tax Incentive and transfer pricing requirements.
Don’t miss this opportunity to position your R&D and clinical trials for success in Australia!
Why Australia?
- Australia is a world class destination for clinical trials.
- State of the art facilities.
- Tap into Australia’s network of skilled professionals.
- Access an R&D rebate of up to 48.5%* of R&D expenditure (conditions apply).
- Efficient ethics and regulatory framework.
- No GMP requirement for most Phase 1 drug products.
- IP can be held on or offshore.
This webinar will be able to be accessed internationally. Please refer to the times below
Session 1 - Start time:
Melbourne (AEDT) - 8am | 29 November
San Francisco (PST) - 1pm | 28 November
London (GMT) - 9pm | 28 November
Boston (EST) - 4pm | 28 November
Zurich (CET) - 10pm | 28 November
Dubai (GST) - 1am | 29 November
Shanghai (CST) - 5am | 29 November
Session 2:
Melbourne (AEDT) - 7pm | 29 November
San Francisco (PST) - 12am | 29 November
London (GMT) - 8am | 29 November
Boston (EST) - 3am | 29 November
Zurich (CET) - 9am | 29 November
Dubai (GST) - 12pm | 29 November
Shanghai (CST) - 4pm | 29 November
You are welcome to share this event with contacts you think may be interested in attending this webinar.
- EVENT DETAILS -
Please note:
Both sessions will feature the same topics and speakers. You do not need to attend both sessions.
Duration:
Both sessions are 1 hour long.
Time:
Please refer to table at the beginning of this page for your location and webinar time.
This is an online webinar via Zoom.
Please note that Zoom access details will be provided upon registration.
If you have any questions, or require further information, please email darien.canepa@rsm.com.au.
Dr. Rita Choueiri | Partner, RSM Australia
Dr. Rita Choueiri, National Director of Life Sciences at RSM Australia, is a leading figure in Research and Development (R&D) Incentives and Grants. Leveraging her scientific background and nearly two decades of consulting experience, she guides STEM companies through the intricacies of R&D Tax Incentives, specialising in securing funding for growth and innovation. Rita’s unique blend of expertise, from drug development to financial strategies, positions her as a crucial bridge between science and finance, benefiting both clients and the industry.
Tony Fulton | Partner, RSM Australia
Tony, a Director in the Tax Services Division at RSM Melbourne, boasts over 25 years of corporate tax expertise, specialising in corporate and international tax services for multinational companies. His extensive advisory background spans various industries, complemented by senior financial management roles in complex ASX-listed firms. Tony’s strategic focus includes providing specialised tax advice for transactions, capital raising, international tax structuring, audit management, and implementing effective tax governance processes for businesses across sectors.
SUPPORTED BY
Legal - RSM Australia Pty Ltd
RSM Australia Pty Ltd , RSM Australia Partners and RSM Financial Services Australia Pty Ltd are members of the RSM network and trade as RSM. Liability limited by a scheme approved under Professional Standards Legislation. RSM is the trading name used by the members of the RSM network.
Each member of the RSM network is an independent accounting and advisory firm each of which practices in its own right. The RSM network is not itself a separate legal entity of any description in any jurisdiction. The RSM network is administered by RSM International Limited, a company registered in England and Wales (company number 4040598) whose registered office is at 50 Cannon Street, London, EC4N 6JJ.
The brand and trademark RSM and other intellectual property rights used by members of the network are owned by RSM International Association, an association governed by article 60 et seq of the Civil Code of Switzerland whose seat is in Zug. Any articles or publications contained within this website are not intended to provide specific business or investment advice. No responsibility for any errors or omissions nor loss occasioned to any person or organisation acting or refraining from acting as a result of any material in this website can, however, be accepted by the author(s) or RSM International. You should take specific independent advice before making any business or investment decision.
© 2019 RSM International Association.
All rights reserved.